Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:14 PM
Ignite Modification Date:
2026-03-26 @ 3:14 PM
NCT ID:
NCT07385495
Eligibility Criteria:
Inclusion Criteria
* Subjects with Allergic Conjunctivitis:
* Age between 5 and 30 years.
* Clinical diagnosis of allergic conjunctivitis.
* Presence of active ocular symptoms at the time of sample collection.
* Positive skin prick test.
* Written informed consent signed by the participant or parent/legal guardian, -with assent when applicable.
Healthy Controls:
* Age between 5 and 30 years.
* Clinically healthy subjects with a normal ocular surface.
* No evidence of active ocular disease.
* Written informed consent signed by the participant or parent/legal guardian, with assent when applicable.
Exclusion Criteria
* Subjects with Allergic Conjunctivitis:
* History of infectious disease within 2 months prior to sample collection.
* Presence of active systemic allergic diseases (e.g., asthma, active dermatitis).
* Chronic degenerative or autoimmune diseases.
* Use of topical immunosuppressive treatment within 2 months prior to sample collection.
* Use of systemic immunosuppressive therapy.
Healthy Controls:
-History of infectious disease within 2 months prior to sample collection.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
5 Years
Maximum Age:
30 Years
Study:
NCT07385495
Study Brief:
Protocol Section:
NCT07385495